APP and Alzheimer disease: The NIA-AA definition introduces the so-called AT(N) classification to standardize biomarker findings in AD: therein A stands for positive Abeta biomarkers, T for phospho-Tau biomarkers, and N for Neurodegeneration markers in cerebrospinal fluid (total Tau burden) or atrophy shown in magnetic resonance imaging (MRI).